Study Stopped
This study was not started due to administrative considerations.
Prenatal Diagnosis and Treatment of Flat, Inverted and Retracted Nipples
FIRN
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The objectives of this study are to determine the population occurrence rate of flat, inverted, or retracted nipples (FIRN) in pregnant women in our obstetrical practice through prenatal evaluation at the NOB visit and re-evaluation at the 28th-30th week of gestation, to determine the benefit of using Supple Cups as treatment for FIRN for 6-8 weeks in the third trimester to evert the nipples prior to delivery, and to evaluate the effect of prenatal diagnosis and treatment of FIRN on establishment of latch and breastfeeding rates in the postpartum period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2021
CompletedFirst Posted
Study publicly available on registry
October 4, 2021
CompletedStudy Start
First participant enrolled
December 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedDecember 15, 2022
December 1, 2022
1 year
September 6, 2021
December 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent of women with change in nipple elongation following use of Supple Cups in the prenatal period
Visual assessment and documented description of change in elongation of nipple after using Supple Cups prior to birth
At completion of 6 weeks of Supple Cups use during the prenatal period
Secondary Outcomes (1)
Percent of women with established breastfeeding with adequate infant latch
One week postpartum
Study Arms (1)
Pregnant women with FIRN
EXPERIMENTALWomen desiring to breastfeed and identified during their pregnancy as having flat, inverted or retracted nipples
Interventions
For pregnant women identified with FIRN and providing consent to participate in this study, Supple Cup usage will be initiated at 32 weeks gestation to begin to elongate the nipples in preparation for breastfeeding.
Eligibility Criteria
You may qualify if:
- Women ≥ 18 years of age
- Pregnant at time of enrollment
- Plan to breastfeed their infant following birth
- Plan delivery at Mayo Clinic Hospital
- One or more flat, inverted or retracted nipple diagnosed by a healthcare professional
You may not qualify if:
- History of breast surgery or nipple piercings
- History of significant low milk supply requiring discontinuation of breastfeeding prior to six weeks postpartum
- History of preterm labor and/or birth
- History of high-risk medical condition that increases patient risk for preterm labor and/or birth
- History of Raynaud's syndrome and/or hypersensitivity to palpation of breasts
- Current multiple gestation pregnancy
- Active rash, infection, or lesions on the nipple at time of initiation of Supple Cups
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic in Rochester, Minnesota
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Miriam E Levi, CNM, MBA
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 6, 2021
First Posted
October 4, 2021
Study Start
December 1, 2022
Primary Completion
December 1, 2023
Study Completion
March 1, 2024
Last Updated
December 15, 2022
Record last verified: 2022-12